News | Artificial Intelligence | September 22, 2022

Avicenna.AI Partners With deepc to Revolutionize Stroke Patient Care

Avicenna.AI are a medical imaging AI developer, optimizing radiologists’ manual tasks and identifying acute abnormalities. This partnership involves their stroke product suite, which enables automatic identification and triage for acute stroke.

September 22, 2022 — Medical imaging specialist Avicenna.AI announced a groundbreaking partnership with the MedTech company deepc, offering one of the leading radiology AI platforms (deepcOS), to give healthcare providers access to their stroke suite. This move facilitates a step change in patient management for stroke, enabling rapid treatment decisions by combining a uniquely comprehensive stroke management technology with a platform that seamlessly integrates into radiologist’s clinical workflow. 

Every Second Counts. Avicenna.AI’s stroke suite gives radiologists exactly the tools they need to rapidly and automatically identify, triage, and assess patients, enabling faster decision-making and saving lives. 

Avicenna.AI’s CINA stroke suite provides a full range of tools powered by deep learning to automatically identify acute abnormalities and support the emergency imaging department. It comprises two FDA-cleared, CE-marked tools for automatic triage, and one CE-marked quantification tool: 

  • CINA-LVO is a triage tool that instantly flags suspected Large Vessel Occlusion (LVO) on CT angiography. Given that every minute of untreated LVO means two million neurons are lost, early diagnosis is critical. 
  • Real-time trial tool CINA-ICH highlights suspected acute Intracranial Hemorrhage (ICH) on CT scans, efficiently prioritizing cases, drastically reducing the time to treatment. ICH affects over two million people worldwide with a 40-50% mortality rate within one month, so accurate early detection and treatment are vital. 
  • CINA-ASPECTS is a quantification tool that automatically measures an ASPECT Score to assess ischemic changes in stroke. CINA-ASPECTS enables faster, more consistent, and more precise interpretations for assessing acute ischemic stroke. 

To reach its potential, this technology needs to be available to those who need it. That’s where deepc comes in, by creating a cutting-edge AI ecosystem providing radiologists instant access to AI-powered technologies. The platform is changing the way AI is adopted by integrating directly into the clinical workflow. Avicenna.AI’s full stroke suite is now available through the platform, meaning more physicians and patients can benefit from its tools than ever before. 

John Moulden, Chief Commercial Officer at deepc, commented “Our companies bring a challenger mindset to this amazing partnership, and together we offer truly revolutionary technology to healthcare providers and their radiology departments. Looking forward to working together with Avicenna.AI!“ 

Olivier Fuseri, Sales Manager at Avicenna.AI, commented “We are thrilled that our solutions for Stroke are integrated in such a ground-breaking platform as deepcOS. Together we are committed to transform the future of radiology through our combined technologies. 

For more information: https://avicenna.ai 


Related Content

News | Stroke

March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...

Home March 05, 2024
Home
News | Stroke

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 05, 2024
Home
News | Stroke

February 26, 2024 — Ischemic strokes are a major health burden. They occur when a blood vessel that supplies the brain ...

Home February 26, 2024
Home
News | Stroke

February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...

Home February 15, 2024
Home
News | Stroke

February 13, 2024 — RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow ...

Home February 13, 2024
Home
News | Stroke

February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 12, 2024
Home
News | Stroke

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...

Home February 09, 2024
Home
News | Stroke

February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...

Home February 07, 2024
Home
News | Stroke

February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...

Home February 07, 2024
Home
News | Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

Home January 15, 2024
Home
Subscribe Now